Mizuho lifts Quest Diagnostics target to $178 on strong outlook
Securities showed confidence in Quest Diagnostics (NYSE:DGX) by increasing the company's price target to $178 from the previous target of $177, while reaffirming an Outperform stock rating. The ...
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.33, expectations were $2.19. Operator: Welcome to the Quest Diagnostics ...
Positive Outlook for Quest Diagnostics: Strong Financial Performance and Promising Growth Projections
Morgan Stanley analyst Erin Wright has maintained their bullish stance on DGX stock, giving a Buy rating yesterday.Invest with Confidence: ...
Quest Diagnostics: Strong Financial Performance and Strategic Growth Drive Positive Buy Recommendation
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on DGX stock, giving a Buy rating yesterday.Invest with Confidence: ...